The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
Abstract
CONTEXT: Herpes simplex virus type 1 (HSV-1) and type 2 are common infections worldwide. Herpes simplex virus type 2 (HSV-2) is the cause of most genital herpes and is almost always sexually transmitted. In contrast, HSV-1 is usually transmitted during childhood via nonsexual contacts. Preexisting HSV-1 antibodies can alleviate clinical manifestations of subsequently acquired HSV-2. Furthermore, HSV-1 has become an important cause of genital herpes in some developed countries. OBJECTIVE: To examine trends in HSV-1 and HSV-2 seroprevalence in the United States in 1999-2004 compared with 1988-1994. DESIGN, SETTINGS, AND PARTICIPANTS: Cross-sectional, nationally representative surveys (US National Health and Nutrition Examination Surveys [NHANES]), were used to compare national seroprevalence estimates from 1999-2004 with those from 1988-1994, and changes in HSV-1 and HSV-2 seroprevalence since 1976-1980 were reviewed. Persons aged 14 to 49 years were included in these analyses. MAIN OUTCOME MEASURES: Seroprevalence of HSV-1 and HSV-2 antibodies based on results from type-specific immunodot assays; diagnosis of genital herpes. RESULTS: The overall age-adjusted HSV-2 seroprevalence was 17.0% (95% confidence interval [CI], 15.8%-18.3%) in 1999-2004 and 21.0% (95% CI, 19.1%-23.1%) in 1988-1994, a relative decrease of 19.0% between the 2 surveys (95% CI, -28.6% to -9.5%; P<.001). Decreases in HSV-2 seroprevalence were especially concentrated in persons aged 14 to 19 years between 1988 and 2004. In adolescents aged 17 to 19 years and young adults, the decreases in HSV-2 seroprevalence were significant even after adjusting for changes in sexual behaviors. Among those infected with HSV-2, the percentage who reported having been diagnosed with genital herpes was statistically different (14.3% in 1999-2004 and 9.9% in 1988-1994; P = .02). Seroprevalence of HSV-1 decreased from 62.0% (95% CI, 59.6%-64.6%) in 1988-1994 to 57.7% (95% CI, 55.9%-59.5%) in 1999-2004, a relative decrease of 6.9% between the 2 surveys (95% CI, -11.6% to -2.3%; P = .006). Among persons infected with HSV-1 but not with HSV-2, a higher percentage reported having been diagnosed with genital herpes in 1999-2004 compared with 1988-1994 (1.8% vs 0.4%, respectively; P<.001). CONCLUSIONS: These data show declines in HSV-2 seroprevalence, suggesting that the trajectory of increasing HSV-2 seroprevalence in the United States has been reversed. Seroprevalence of HSV-1 decreased but the incidence of genital herpes caused by HSV-1 may be increasing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, C. F., Ku, L., Rogers, S. M., Lindberg, L. D., Pleck, J. H., & Sonenstein, F. L. (1998) · Science · doi:10.1126/science.280.5365.867 · Cited by 2,046
On judging the significance of differences by examining the overlap between confidence intervals.
Schenker, N., & Gentleman, J. F. (2001) · The American Statistician · doi:10.1198/000313001317097960 · Cited by 1,218
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371601 · Cited by 1,189
Self-citation(2001) · Technometrics · doi:10.1198/tech.2001.s612 · Cited by 989
Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review
Smith, J. S., & Robinson, N. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/343739 · Cited by 885
Survival Models and Data Analysis.
Kay, R., Elandt-Johnson, R. C., & Johnson, N. L. (1982) · The Statistician · doi:10.2307/2987637 · Cited by 829
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 794
Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S. K., Warren, T., Douglas, J. M., Paavonen, J., Morrow, R. A., Beutner, K. R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035144 · Cited by 720
Sexual Behavior and Selected Health Measures: Men and Women 15-44 Years of Age, United States, 2002
Mosher, W. D., Chandra, A., & Jones, J. (2005) · PsycEXTRA Dataset · doi:10.1037/e609202007-001 · Cited by 693
Wald, A., & Link, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338231 · Cited by 691
Brown, Z. A., Wald, A., Morrow, R. A., Selke, S., Zeh, J., & Corey, L. (2003) · JAMA · doi:10.1001/jama.289.2.203 · Cited by 679
Ashley, R. L., Militoni, J., Lee, F., Nahmias, A., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 541
Self-citationSero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.
Nahmias, A. J., Lee, F. K., & Beckman-Nahmias, S. (1990) · PubMed · Cited by 531
Self-citationA Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2
Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 510
Roberts, C. M., Pfister, J. R., & Spear, S. J. (2003) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000092387.58746.c7 · Cited by 379
Prior Herpes Simplex Virus Type 2 Infection as a Risk Factor for HIV Infection
Holmberg, S. D. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720070048033 · Cited by 367
Profile of the foreign-born population in the United States.
Bachu, A. (1991) · PubMed · Cited by 359
Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women
Wald, A. (2001) · JAMA · doi:10.1001/jama.285.24.3100 · Cited by 321
Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1–Infected Men
Schacker, T. (1998) · JAMA · doi:10.1001/jama.280.1.61 · Cited by 309
Oral Versus Vaginal Sex Among Adolescents: Perceptions, Attitudes, and Behavior
Halpern-Felsher, B. L., Cornell, J. L., Kropp, R. Y., & Tschann, J. M. (2005) · Pediatrics · doi:10.1542/peds.2004-2108 · Cited by 287
Xu, F., Schillinger, J. A., Sternberg, M. R., Johnson, R. E., Lee, F. K., Nahmias, A. J., & Markowitz, L. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/340041 · Cited by 252
Self-citationThe seroepidemiology of herpes simplex virus type 1 and 2 in Europe
Pebody, R. G. (2004) · Sexually Transmitted Infections · doi:10.1136/sti.2003.005850 · Cited by 238
Serological Testing for Herpes Simplex Virus (HSV)–1 and HSV‐2 Infection
Wald, A., & Ashley‐Morrow, R. (2002) · Clinical Infectious Diseases · doi:10.1086/342104 · Cited by 207
Reynolds, S. J., Risbud, A. R., Shepherd, M. E., Zenilman, J. M., Brookmeyer, R. S., Paranjape, R. S., Divekar, A. D., Gangakhedkar, R. R., Ghate, M. V., Bollinger, R. C., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/368357 · Cited by 206
Trends in Sexual Risk Behaviors Among High School Students—United States, 1991-1997
(1998) · JAMA · doi:10.1001/jama.280.21.1819-jwr1202-2-1 · Cited by 199
Schacker, T., Zeh, J., Hu, H., Shaughnessy, M., & Corey, L. (2002) · The Journal of Infectious Diseases · doi:10.1086/345771 · Cited by 196
Vyse, A. J. (2000) · Sexually Transmitted Infections · doi:10.1136/sti.76.3.183 · Cited by 189
Serwadda, D., Gray, R. H., Sewankambo, N. K., Wabwire‐Mangen, F., Chen, M. Z., Quinn, T. C., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/379333 · Cited by 171
Natural History of Genital Herpes Simplex Virus Type 1 Infection
ENGELBERG, R., CARRELL, D., KRANTZ, E., COREY, L., & WALD, A. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200302000-00015 · Cited by 170
Kimberlin, D. W., & Rouse, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp023065 · Cited by 168
The Relationship between Condom Use and Herpes Simplex Virus Acquisition
Wald, A., Langenberg, A. G. M., Krantz, E. M., Douglas, J. M., Handsfield, H. H., DiCarlo, R. P., Adimora, A. A., Izu, A., Morrow, R. A., & Corey, L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00007 · Cited by 159
Association between cervical shedding of herpes simplex virus and HIV-1
McClelland, R. S., Wang, C. C., Overbaugh, J. M., Richardson, B. A., Corey, L., Ashley, R. L., Mandaliya, K. N., Ndinya‐Achola, J. O., Bwayo, J. J., & Kreiss, J. K. (2002) · AIDS · doi:10.1097/00002030-200212060-00007 · Cited by 140
Löwhagen, G. B. (2000) · Sexually Transmitted Infections · doi:10.1136/sti.76.3.179 · Cited by 137
National Seroprevalence and Trends in Herpes Simplex Virus Type 1 in the United States, 1976–1994
Schillinger, J. A., Xu, F., Sternberg, M., Armstrong, G. L., Lee, F. K., Nahmias, A. J., McQuillan, G. M., Louis, M. E. S., & Markowitz, L. E. (2004) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000145852.43262.c3 · Cited by 130
Self-citationA novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies
Lee, F. K., Pereira, L., Griffin, C., Reid, E., & Nahmias, A. J. (1986) · Journal of Virological Methods · doi:10.1016/0166-0934(86)90041-8 · Cited by 129
Self-citationSantelli, J. S., Abma, J. C., Ventura, S. J., Lindberg, L., Morrow, B., Anderson, J. E., Lyss, S. B., & Hamilton, B. E. (2004) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2004.05.001 · Cited by 129
Herpes Simplex Viruses 1 and 2
Nahmias, A. J., & Josey, W. E. (1982) · Springer eBooks · doi:10.1007/978-1-4613-3237-4_13 · Cited by 116
Self-citationRibes, J. A., Steele, A. D., Seabolt, J. P., & Baker, D. J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3321-3325.2001 · Cited by 83
Celum, C., Robinson, N. J., & Cohen, M. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/425272 · Cited by 81
Scoular, A., Norrie, J. D., Gillespie, G., et al. (2002) · BMJ · doi:10.1136/bmj.324.7350.1366 · Cited by 80
Renzi, C., Douglas, J. M., Foster, M., Critchlow, C. W., Morrow, R. A., Buchbinder, S., Koblin, B. A., McKirnan, D. J., Mayer, K. H., & Celum, C. (2002) · The Journal of Infectious Diseases · doi:10.1086/345867 · Cited by 78
Hashido, M., Kawana, T., Matsunaga, Y., & Inouye, S. (1999) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1999.tb02390.x · Cited by 41
Cited by
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Prevalence of HPV Infection Among Females in the United States
Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., & Markowitz, L. E. (2007) · JAMA · doi:10.1001/jama.297.8.813 · Cited by 1,579
Self-citationSexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Self-citationWhitley, R. J., & Roizman, B. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0597 · Cited by 700
Metadata
- Authors
- Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., Berman, S. M., & Markowitz, L. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-08-23
- Volume
- 296
- Issue
- 8
- Pages
- 964
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1985339853
- Cited by
- 1,035
- References
- 43
- FWCI
- 47.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.